SECTION // 09 — INPUT CHANNEL
Contact This Field Terminal
Editorial inquiries about the BPC-157 TB-500 digest — corrections, source questions, and citation requests. This is not a clinical or sales channel.
What this channel is for
Use the form below for editorial matters: a correction to a summary, a question about a cited source, or a request for the citation behind a specific claim. We read every message about the accuracy of the record.
Clinic Wolverine is an editorial publisher, not a clinic or a vendor. We cannot answer requests for medical advice, dosing guidance, prescriptions, or product purchases, because we provide none of those things. We do not diagnose, treat, or consult, and we do not sell or supply BPC-157, TB-500, or any blend. For questions about clinical care, consult a licensed healthcare professional; for the regulatory landscape, see Wolverine legal status and FDA 503A category.
Editorial contact form
The form collects a name, an email address, a subject, and a message. It routes to the site's editorial inbox and is used only to respond to the inquiry. We do not add submitted addresses to any mailing list, and we do not share them.
If you are flagging a factual error, a note of the page and the specific sentence helps us check it against the source quickly. Corrections that hold up against the cited record are made promptly, and the reference list is updated where a source needs to be added or amended.
The most useful messages point to a number and its source: a dose we have mis-stated, a study we have misattributed, a citation that does not resolve, or a regulatory fact that has moved. Because the regulatory picture for both of this blend's components is under active FDA review, the legal-status page is the page most likely to need updating over time — if you see the present-tense status change at an authoritative FDA source, that is exactly the kind of note this channel exists to receive.